IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#3743
Positioning
Market Dominance
Manufacturing
Pharmaceutical Products
$4M
Amro Albanna
Aditxt, Inc. develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. The company is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | 28.5% | 8.0% | 100.0% | 100.0% | 10.4% | -4.6% | 3.3% | 0.0x | $141.8B | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | 46.1% | 16.6% | 51.3% | 31.9% | 26.8% | -4.0% | 1.0% | 25.0x | $272.1B | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | 10.3% | 3.1% | 24.1% | 7.2% | 4.7% | 14.3% | 0.8% | 25.0x | $11.4B | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | 2.2% | 1.5% | 9.3% | 5.3% | 2.2% | -8.5% | 2.2% | 16.0x | $18.9B | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 35.5% | 19.8% | 48.7% | 29.2% | 24.7% | 4.4% | 0.8% | 32.0x | $181.9B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | 11.8% | 8.8% | 45.9% | 11.3% | 11.1% | 25.7% | 3.7% | 0.0x | $1.8B | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.6% | 7.0% | 66.5% | 17.1% | 15.6% | 39.0% | 0.0% | 0.0x | $115M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | 22.6% | 4.9% | 71.2% | 12.8% | 9.4% | 1.7% | 5.9% | 124.0x | $72.1B | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | 3.0% | 1.1% | 20.9% | 7.3% | 1.3% | 3.0% | 0.9% | 67.0x | $1.2B | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | 8.2% | 3.5% | 55.3% | 25.9% | 12.4% | 0.7% | 1.7% | 0.0x | $87.0B | VS | |
$ADTX Aditxt, Inc. | 38 | 30 | 28 | 52 | - | - | 1790.5% | -377.4% | -1672.9% | -413035.6% | -1164875.8% | -98.3% | 0.0% | - | $4M | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -2.5% | -0.1% | 42.5% | 1.3% | -0.2% | 5.9% | 0.0% | 0.2x | - | REF |
Aditxt, Inc. (ADTX) receives a "Avoid" rating with a composite score of 38.4/100. It ranks #3743 out of 7,333 stocks in our coverage universe and carries a 1-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Direct cash return
Amro Albanna
Chief Executive Officer
Labor Force
60
30
36
2
Audit Verdict: Lower quality and stability scores may indicate governance concerns.
No recent insider transactions available for ADTX
In-line with peers — no strong momentum signal
Expensive relative to fundamentals — limited margin of safety
Weak fundamentals — higher risk of value trap
High volatility — wider range of outcomes increases timing risk
Moderate investment profile
Below-average composite — caution warranted
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for ADTX.
View All RatingsHigh margin volatility — erratic forensic earnings quality
ROIC -52.5% vs WACC 50.6% (spread -103.1%)
GM -1673% vs sector 43%, OM -413036% vs sector 1%
Capital turnover 0.00x, R&D intensity 95508.2%
Rev growth -98%, 6yr history
Interest coverage -4.1x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our quantitative model flags Aditxt, Inc. with an Avoid rating, assigning a composite score of 38.4/100 and 1 out of 5 stars. Ranked #3743 of 7,333 stocks, ADTX falls in the bottom tier across key factors. Historically, stocks with this profile have faced elevated risk of underperformance and capital loss.
ADTX's quality score of 30/100 is below average, suggesting challenges with profitability or capital efficiency. The company reports a return on equity of 1790.5% (sector avg: -2.5%), gross margins of -1672.9% (sector avg: 42.5%), net margins of -1164875.8% (sector avg: -0.2%). Investors should examine whether management is actively addressing these weaknesses or if they reflect structural industry headwinds.
ADTX registers a value score of just 28/100, suggesting the stock trades at a significant premium to its fundamental metrics. High-premium valuations like this require strong future execution to avoid multiple compression, and downside risk is elevated if growth disappoints.
Aditxt, Inc.'s investment score of 36/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of -98.3% vs. a sector average of 5.9% and a return on assets of -377.4% (sector: -0.1%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
ADTX demonstrates moderate momentum with a score of 52/100, suggesting a neutral price trend without strong directional conviction. Revenue growth stands at -98.3% year-over-year, while a beta of 45.96 reflects its sensitivity to broader market moves. Moderate momentum may indicate the stock is consolidating or transitioning between trends, warranting close monitoring of upcoming catalysts.
Aditxt, Inc. registers a low stability score of 2/100, indicating high volatility and potentially stressed financial conditions. Key stability metrics include a beta of 45.96. Stocks at this level carry elevated capital loss risk and may be unsuitable for conservative portfolios without careful risk management.
ADTX's short interest factor score of 88/100 indicates very low short selling activity relative to peers — a positive signal suggesting institutional investors see limited near-term downside. Specific risk factors include high market sensitivity (beta: 45.96), micro-cap liquidity risk. As a micro-cap company with a market capitalization of $4M, Aditxt, Inc. benefits from the generally lower volatility and deeper liquidity associated with its size class.
Aditxt, Inc. is a micro-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #3743 of 7,333 overall (49th percentile). Key comparisons include ROE of 1790.5% exceeding the -2.5% sector median and operating margins of -413035.6% below the 1.3% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
While ADTX currently exhibits a AVOID profile, superior opportunities exist within the MANUFACTURING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Manufacturing Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Stability (2) would have the largest impact on the composite score.
ROE 72299% BELOW SECTOR MEDIAN
Gross Margin 4036% BELOW SECTOR MEDIAN
Op. Margin 32018361% BELOW SECTOR MEDIAN
AUDIT DATA AS OF SEP 30, 2025 (Q2 FY2025)
We rate Aditxt, Inc. (ADTX) as Avoid with a composite score of 38.4/100 at a current price of $0.52. The stock falls in the bottom quintile of our universe across key quantitative factors, and the multi-factor weakness suggests a high probability of continued underperformance.
The rating is primarily driven by strength in momentum (52th percentile) and investment (36th percentile), which together account for the majority of the composite score. Offsetting weakness in stability (2th percentile) and value (28th percentile) tempers our overall conviction. We assign a No Moat rating (14/100), Very High uncertainty, and Poor capital allocation.
Key items to watch: the path to profitability; valuation compression risk if growth disappoints. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
Aditxt, Inc. holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 38.4/100 places it at rank #3743 in our full 7,333-stock universe. At $4M in market capitalization, Aditxt, Inc. is a small-cap player in the Manufacturing space, which limits certain scale advantages but may allow for more agile strategic execution.
Revenue contraction of -98% combined with momentum at the 52th percentile paints a cautious picture of the near-term business outlook. The market appears to be pricing in continued challenges, and a catalyst for reversal is not clearly visible from current data.
The margin cascade tells an important story: gross margins of -1673% (-1715.4pp vs sector) narrow to operating margins of -413036% (-413036.9pp vs sector) and net margins of -1164875.8%, yielding a gross-to-net conversion rate of N/A%. The significant margin erosion from gross to net suggests elevated operating expenses, high interest costs, or other structural drags that warrant monitoring.
At a current price of $0.52, Aditxt, Inc. is trading at a premium to fundamental value. Our value factor score of 28/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. The premium valuation implies the market is pricing in significant future growth or quality improvements that are not yet fully reflected in current fundamentals.
The stock currently trades at P/S of 94.1x. We evaluate these multiples in the context of both absolute levels and sector-relative positioning to form our valuation view.
Returns on equity of 1790.5% exceed the cost of equity for most companies, indicating genuine shareholder value creation and a reinvestment engine that compounds wealth over time.
The Avoid rating (composite 38.4/100) reflects multi-factor weakness, and historically, stocks in this scoring range have underperformed the market by a meaningful margin.
Revenue decline of -98% signals business deterioration — declining revenues make it difficult to grow into the current valuation and often precede further negative revisions.
Thin net margins of -1164875.8% provide limited cushion against cost pressures, competitive pricing, or macroeconomic headwinds — even small changes in costs could swing the company to a loss.
Below-average quality (30th percentile) raises durability concerns about the fundamental profile and increases the risk of negative earnings surprises.
We assign a Very High uncertainty rating to Aditxt, Inc.. The stock exhibits multiple compounding risk factors: elevated market sensitivity (beta of 45.96), current negative profitability (net margin -1164875.8%), below-average price stability (2th percentile). The extreme uncertainty around future cash flows makes precise valuation difficult, and the range of outcomes is exceptionally wide. Only investors with high risk tolerance and extended time horizons should consider this name.
Specific risk factors that inform our assessment include: elevated market sensitivity (beta of 45.96); current negative profitability (net margin -1164875.8%); below-average price stability (2th percentile); weak quality scores (30th percentile). Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 2th percentile and quality factor at the 30th percentile provide a quantitative summary of the overall risk landscape.
We identify limited risk mitigants at this time, which contributes to our very high uncertainty assessment. Investors should monitor for improvement in balance sheet metrics, margin stability, and business predictability that could warrant a downgrade in our risk assessment over time.
We rate Aditxt, Inc.'s capital allocation as Poor. Key concerns include negative profitability, weak asset returns (ROA -377.4%). Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — Aditxt, Inc. significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, Aditxt, Inc. receives a Avoid rating with a composite score of 38.4/100 (rank #3743 of 7,333). Our quantitative framework assigns a No Moat (14/100, trend: stable), Very High uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 29/100.
Our analysis does not support a constructive view on Aditxt, Inc. at this time. The combination of limited competitive advantages, very high uncertainty, and poor capital allocation suggests unfavorable risk-reward at current levels. We recommend investors avoid new positions and existing holders consider reducing exposure.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We do not assign Aditxt, Inc. a meaningful economic moat, scoring 14/100 on our composite assessment. The ROIC-WACC spread of -103.1% is the primary signal of economic value creation. Current fundamentals do not demonstrate the kind of durable competitive advantages — such as superior returns on invested capital, margin superiority, or reinvestment efficiency — that would protect the company from competitive erosion over the long term. The highest-scoring pillar, reinvestment efficiency, reached only 7/20.
The strongest moat sources are reinvestment efficiency (7/20) and economic value creation (2.5/20). Capital turnover 0.00x, R&D intensity 95508.2%. ROIC -52.5% vs WACC 50.6% (spread -103.1%). These pillars form the core of Aditxt, Inc.'s competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include margin superiority (0/20) and growth durability (2.3/20). GM -1673% vs sector 43%, OM -413036% vs sector 1%. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect Aditxt, Inc.'s moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include declining revenues (-98%) that pressure the earnings outlook, returns on equity of 1790.5% driving shareholder value creation. The margin cascade from -1673% gross to -413036% operating to -1164875.8% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that profit quality raises some durability concerns, with the quality factor at the 30th percentile.
The margin profile shows gross margins of -1673%, operating margins of -413036%, net margins of -1164875.8%. Return metrics include ROE of 1790.5% and ROA of -377.4%. Relative to the Manufacturing sector, gross margins are 1715.4 percentage points below the sector median of 43%, and ROE of 1790.5% compares to a sector median of -2.5%.
The balance sheet reflects revenue growth of -98%. Overall balance sheet health is adequate for the current business environment.
High beta of 45.96 means amplified losses in market selloffs — in a broad market correction, this stock would likely decline more than the index.
Above 50MA
37.18%
Net New Highs
+51081

U.S. stock futures rose on Wednesday after a mixed market close, with uncertainty surrounding November's jobs report and potential Federal Reserve interest rate decisions. Key companies reported earnings with varied results.

Evofem Biosciences shareholders rejected a proposed merger with Aditxt, leading the company to terminate the merger agreement and pivot towards regaining a national stock listing and securing growth capital.

Evofem Biosciences plans to merge with Aditxt, with a stockholder meeting scheduled for September 26, 2025. The company believes it has sufficient voting support to approve the merger, which would position Evofem as a subsidiary of Aditxt focused on women's healthcare innovations.

Women's health innovator Evofem Biosciences reported increased net sales of $4.8 million in Q2 2025, improved operational losses, and advanced global market strategies for its contraceptive and antibiotic products while preparing for a merger with Aditxt.

Evofem Biosciences reported Q2 2025 financial results with 16% revenue growth to $4.8 million, driven by SOLOSEC acquisition and PHEXXI price adjustment. Despite operational improvements, the company experienced a net loss of $1.8 million and faces liquidity challenges ahead of a pending merger with Aditxt.